13F reference period
Q2 2026
Security Snapshot
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share (CNTB) Institutional Ownership
CUSIP: G23549101
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
55
Shares (Excl. Options)
13.87M
Full value: 13,874,380 · shares · 30 Jun 2026Price
$2.38
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value $0.000174 per Share
- Symbol
- CNTB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 13,874,380
- Total 13F value
- $33,020,003
- Portfolio coverage rank
- 0%
- Share change
- +1,125,656
- Value change
- +$2,553,909
- Number of holders
- 55
- Shares outstanding
- 62,989,660
- SEC-reported price per share
- $1.10
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share is tracked under CUSIP G23549101.
- 55 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 40 to 55 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$32.37M
Full value: $32,367,682 · USD · 31 Mar 2026.$33.02M
Full value: $33,020,003 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 55 institutions filings for Q2 2026.
Security key
G23549101
13F reference period
Q2 2026
13F holders
55
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
CNTB full holder history
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Connect Biopharma Holdings Ltd insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G23549101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
CNTB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Panacea Innovation Ltd | 21% | -1.4% | $36,848,000 | +$3,248,000 | 13,160,000 | +9.7% | Panacea Innovation Limited | 31 Mar 2026 |
| BML Investment Partners, L.P. | 6.8% | $8,784,664 | 4,264,400 | Braden M Leonard | 30 Sep 2026 |
As of 30 Jun 2026,
55
institutional investors reported holding
shares of
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per Share (CNTB).
This represents
22%
of the company’s total
outstanding shares.
13.87M
Full value: 13,874,380 · shares · 30 Jun 202662.99M
Full value: 62,989,660 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
21%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 7.2% | 4,538,534 | -16% | 1.8% | $10,801,710 |
| 683 Capital Management, LLC | 2% | 1,285,000 | +43% | 0.28% | $3,058,300 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.5% | 973,732 | -21% | 0.04% | $2,317,482 |
| BlackRock, Inc. | 1.4% | 871,653 | 0% | $2,074,534 | |
| PERCEPTIVE ADVISORS LLC | 1.3% | 792,696 | 0% | 0.03% | $1,886,616 |
| ADAR1 Capital Management, LLC | 1.1% | 700,000 | -5.7% | 0.08% | $1,666,000 |
| BML Capital Management, LLC | 0.91% | 573,287 | +40% | 0.78% | $1,364,423 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.87% | 545,000 | 0.14% | $1,297,100 | |
| Richmond Brothers, Inc. | 0.85% | 535,612 | +12% | 0.66% | $1,274,755 |
| Knott David M Jr | 0.71% | 444,862 | +15% | 0.57% | $1,058,772 |
| Stonepine Capital Management, LLC | 0.58% | 364,254 | +18% | 0.66% | $866,925 |
| MARSHALL WACE, LLP | 0.53% | 335,642 | +408% | 0% | $798,830 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.41% | 257,454 | +701% | 0% | $612,740 |
| TWO SIGMA INVESTMENTS, LP | 0.32% | 199,381 | +320% | 0% | $474,527 |
| DIADEMA PARTNERS LP | 0.31% | 196,985 | -1.8% | 0.18% | $468,824 |
| Burkehill Global Management, LP | 0.24% | 150,000 | 0% | 0.01% | $357,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.16% | 102,755 | 0% | $244,557 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.16% | 102,148 | -63% | 0% | $243,112 |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 87,300 | -28% | 0% | $207,774 |
| NORTHERN TRUST CORP | 0.13% | 82,862 | 0% | $197,212 | |
| SIMPLEX TRADING, LLC | 0.13% | 81,948 | 0.01% | $195,036 | |
| STATE STREET CORP | 0.11% | 66,700 | 0% | $158,746 | |
| UBS Group AG | 0.11% | 66,451 | +201267% | 0% | $158,153 |
| Persistent Asset Partners Ltd | 0.08% | 49,873 | -1.7% | 0.04% | $118,698 |
| Koa Wealth Management, LLC | 0.08% | 49,600 | 0% | 0.08% | $118,048 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 68,078 | $74,386 | -$35,397 | $1.10 | 7 |
| 2026 Q2 | 13,874,380 | $33,020,003 | +$2,553,909 | $2.38 | 55 |
| 2026 Q1 | 12,746,434 | $32,367,682 | +$11,059,918 | $2.62 | 40 |
| 2025 Q4 | 8,464,921 | $23,870,814 | +$21,721,782 | $2.82 | 28 |
| 2025 Q3 | 1,621,133 | $2,443,403 | +$2,443,403 | $1.48 | 15 |